Association of frequency of hereditary hemochromatosis (HFE) gene mutations (H63D and C282Y) with iron overload in beta-thalassemia major patients in Pakistan

References

1. ↵
   1. Cappellini MD,
   2. Viprakasit V,
   3. Taher AT

   (2014) An overview of current treatment strategies for ß-thalassemia. Expert Opinion on Orphan Drugs 2:665–679.

   OpenUrl
2. ↵
   1. Al-Khabori M,
   2. Bhandari S,
   3. Al-Rasadi K,
   4. Mevada S,
   5. Al-Dhuhli H,
   6. Al-Kemyani N,
   7. et al.

   (2014) Correlation of iron overload and glomerular filtration rate estimated by cystatin C in patients with ß-thalassemia major. Hemoglobin 38:365–368.

   OpenUrl
3. ↵
   1. Ali N,
   2. Ahmed B,
   3. Akram H,
   4. Akhtar J,
   5. Williams R,
   6. Dixon R

   (2018) HFE gene mutations. The Professional Medical Journal 25:129–134.

   OpenUrl
4. ↵
   1. Dasgupta A,
   2. Roy S,
   3. Sinharay M

   Prevalance of H63D and C282Y Mutation and Its Association with Iron Overload in Thalassemia Patients in an Eastern Indian Population. Journal of Advances in Medicine and Medical Research 2017:1–10.
5. ↵
   1. Soltanpour MS,
   2. Davari K

   (2018) The correlation of cardiac and hepatic hemosiderosis as measured by T2*MRI technique with ferritin levels and hemochromatosis gene mutations in Iranian patients with beta thalassemia major. Oman Med J 33:48–54.

   OpenUrl
6. ↵
   1. Yang J,
   2. Lun Y,
   3. Shuai X,
   4. Liu T,
   5. Wu Y

   (2018) Late-onset hemochromatosis:Co-inheritance of ß-thalassemia and hereditary hemochromatosis in a Chinese family:a case report and epidemiological analysis of diverse populations. Intern Med 57:3433–3438.

   OpenUrl
7. 1. Enein AA,
   2. El Dessouky NA,
   3. Mohamed KS,
   4. Botros SKA,
   5. Abd El Gawad MF,
   6. Hamdy M,
   7. et al.

   (2016) Frequency of hereditary hemochromatosis (HFE) gene mutations in Egyptian beta thalassemia patients and its relation to iron overload. Open Access Maced J Med Sci 4:226–231.

   OpenUrl
8. ↵
   1. Terzi YK,
   2. BulakbaşıBalcı T,
   3. Boğa C,
   4. Koç Z,
   5. Yılmaz Çelik Z,
   6. Özdoğu H,
   7. et al.

   (2016) Effect of hereditary hemochromatosis gene H63D and C282Y mutations on iron overload in sickle cell disease patients. Turk J Haematol 33:320–325.

   OpenUrl
9. ↵
   1. Nadkarni AH,
   2. Singh AA,
   3. Colaco S,
   4. Hariharan P,
   5. Colah RB,
   6. Ghosh K

   (2017) Effect of the hemochromatosis mutations on iron overload among the Indian ßthalassemia carriers. J Clin Lab Anal 31.
10. ↵
    1. Oliveira T,
    2. Souza F,
    3. Jardim A,
    4. Cordeiro J,
    5. Pinho J,
    6. Sitnik R,
    7. et al.

    (2006) HFE gene mutations in Brazilian thalassemic patients. Braz J Med Biol Res 39:1575–1580.

    OpenUrlPubMed
11. ↵
    1. Valerian DM,
    2. Mauka WI,
    3. Kajeguka DC,
    4. Mgabo M,
    5. Juma A,
    6. Baliyima L,
    7. et al.

    (2018) Prevalence and causes of blood donor deferrals among clients presenting for blood donation in northern Tanzania. PLoS One 13:0206487.

    OpenUrl
12. ↵
    1. Khan BH,
    2. Attaullah S,
    3. Khan AH

    (2017) Frequency of ABO and RH (D) blood groups involving volunteer donors in District Nowshera. Journal of Postgraduate Medical Institute (Peshawar-Pakistan) 31(2).
13. ↵
    1. Lynas C

    (1997) A cheaper and more rapid polymerase chain reaction-restriction fragment length polymorphism method for the detection of the HLA-H gene mutations occurring in hereditary hemochromatosis. Blood 90:4235–4236.

    OpenUrlFREE Full Text
14. ↵
    1. IBM SPSS Statistics for Windows, version 19

    (IBM Corp. Armonk, N.Y., USA).
15. ↵
    1. Ahmed Kiani R,
    2. Anwar M,
    3. Waheed U,
    4. Asad MJ,
    5. Abbasi S,
    6. Abbas Zaheer H

    (2016) Epidemiology of transfusion transmitted infection among patients with ß-thalassaemia major in Pakistan. J Blood Transfus 2016:8135649.

    OpenUrl
16. ↵
    1. Sadia Sultan MBBS F,
    2. Siddiqui M,
    3. Zaidi SMH

    (2016) Current trends of seroprevalence of transfusion transmitted infections in Pakistani [Beta]-thalassaemic patients. Malays J Pathol 38:251–255.

    OpenUrl
17. ↵
    1. Laghari Z,
    2. Baig N,
    3. Charan T,
    4. Lashari K,
    5. Suhag R

    (2018) Distribution of ABO blood groups and rhesus factor in ß-thalassemia patients at thalassemia care center NawabShah, Pakistan. Sindh University Research Journal-SURJ (Science Series) 50:123–128.

    OpenUrl
18. ↵
    1. Ejaz MS,
    2. Baloch S,
    3. Arif F

    (2015) Efficacy and adverse effects of oral chelating therapy (deferasirox) in multi-transfused Pakistani children with ß-thalassemia major. Pak J Med Sci 31:621–625.

    OpenUrl
19. ↵
    1. Rehman H,
    2. Masood J,
    3. Sheikh S,
    4. Mehboob Q

    (2019) Frequency of hypothyroidism in patients of beta thalassemia major (APMC, India).
20. ↵
    1. Trehan A,
    2. Sharma N,
    3. Das R,
    4. Bansal D,
    5. Marwaha R

    (2015) Clinicoinvestigational and demographic profile of children with thalassemia major. Indian J Hematol Blood Transfus 31:121–126.

    OpenUrl
21. ↵
    1. Zamani R,
    2. Khazaei S,
    3. Rezaeian S

    (2015) Survival analysis and its associated factors of Beta thalassemia major in Hamadan province. Iranian Journal of Medical Sciences 40:233.

    OpenUrl
22. ↵
    (2016) Revisiting reactive blood donor demographics-A single center experience. Journal of the Liaquat University of Medical and Health Sciences 15:208–212.

    OpenUrl
23. ↵
    1. Pervaiz A,
    2. Sipra FS,
    3. Rana TH,
    4. Qadeer I

    (2015) Pre-donation screening of volunteer prisoner blood donors for hepatitis B and C in prisons of Punjab, Pakistan. J Ayub Med Coll Abbottabad 27:794–797.

    OpenUrl
24. ↵
    1. Mohamed M,
    2. Phillips J

    (2016) Hereditary haemochromatosis. BMJ 353:3128.

    OpenUrl
25. ↵
    1. Parkash O,
    2. Akram M

    (2015) Hereditary Hemochromatosis. J Coll Physicians Surg Pak 25:644–647.

    OpenUrl
26. ↵
    1. Rasool M,
    2. Malik A,
    3. Jabbar U,
    4. Begum I,
    5. Qazi MH,
    6. Asif M,
    7. et al.

    (2016) Effect of iron overload on renal functions and oxidative stress in beta thalassemia patients. Saudi Med J 37:1239–1242.

    OpenUrlAbstract/FREE Full Text
27. ↵
    1. Saleem M,
    2. Ghafoor MB,
    3. Anwar J,
    4. Saleem MM

    (2016) Hypothyroidism in beta thalassemia major patients at Rahim Yar Khan. Journal of Sheikh Zayed Medical College 7:1016–1019.

    OpenUrl
28. ↵
    1. Skrlec I,
    2. Steiner R,
    3. Wagner J

    (2019) Hereditary hemochromatosis gene mutations in patients with myocardial infarction. Molecular and Experimental Biology in Medicine 2:24–28.

    OpenUrl
29. ↵
    1. Pietrangelo A

    (2015) Genetics, Genetic Testing, and Management of Hemochromatosis:15 Years Since Hepcidin. Gastroenterology 149:1240-e4–1251.e4.

    OpenUrl
30. ↵
    1. Wilson MM,
    2. Al-Wakeel H,
    3. Said F,
    4. El-Ghamrawy M,
    5. Assaad M,
    6. El-Beshlawy A

    (2015) Study of the effect of HFE gene mutations on iron overload in Egyptian thalassemia patients. Egyptian Journal of Medical Human Genetics 16:129–133.

    OpenUrl
31. ↵
    1. Enein AA,
    2. El Dessouky NA,
    3. Mohamed KS,
    4. Botros SK,
    5. El Gawad MFA,
    6. Hamdy M,
    7. et al.

    (2016) Frequency of hereditary hemochromatosis (HFE) gene mutations in Egyptian beta thalassemia patients and its relation to iron overload. Open Access Maced J Med Sci 4:226–231.

    OpenUrl
32. ↵
    1. Fekri K,
    2. Rasouli NA,
    3. Zavareh SAT,
    4. Jalil M,
    5. Moradi F,
    6. Hosseinpour M,
    7. et al.

    (2019) Hepcidin and HFE polymorphisms and ferritin level in ß-Thalassemia major. Int J Hematol Oncol Stem Cell Res 13:42–48.

    OpenUrl
33. ↵
    1. Terzi YK,
    2. Balcı TB,
    3. Boğa C,
    4. Koç Z,
    5. Çelik ZY,
    6. Özdoğu H,
    7. et al.

    (2016) Effect of hereditary hemochromatosis gene H63D and C282Y mutations on iron overload in sickle cell disease patients. Turk J Haematol 33:320–325.

    OpenUrl
34. ↵
    1. Ghaderi A,
    2. Ahmadi MRH,
    3. Hosseini E,
    4. Akbari AAM,
    5. Feyzi AAHP,
    6. Hiradfar A,
    7. et al.

    (2016) Retracted Article:Prevalence of the C282Y and H63D mutations of the HFE hemochromatosis gene in Azerian major ß-thalassemia and iron overload. Comparative Clinical Pathology 25:151–154.

    OpenUrl